Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

A Shi Tzu dog with high cortisol levels improved after increasing the dose of trilostane.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

The CORT, FGF5, and CD36 genes are crucial for the cold weather adaptation of Yanbian cattle.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Scalp hair sweating is a significant predictor of hair cortisol levels.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

High testosterone increases heart disease risk in women with PCOS.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

Spironolactone can reduce hair growth in women with hirsutism.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

PCOS is caused by both genetics and environmental factors like diet and obesity.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.